Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia

Laurits Frøssing*, Thomas Hartvig Lindkaer Jensen, Jesper Østrup Nielsen, Morten Hvidtfeldt, Alexander Silberbrandt, Deborah Parker, Celeste Porsbjerg, Vibeke Backer

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

6 Citationer (Scopus)

Abstract

Introduction: Cell differential count (CDC) of induced sputum is considered the gold standard for inflammatory phenotyping of asthma but is not implemented in routine care due to its heavy time- and staff demands. Digital Cell Morphology is a technique where digital images of cells are captured and presented preclassified as white blood cells (neutrophils, eosinophils, lymphocytes, macrophages, and unidentified) and nonwhite blood cells for review. With this study, we wanted to assess the accuracy of an automated CDC in identifying the key inflammatory cells in induced sputum. Methods: Sputum from 50 patients with asthma was collected and processed using the standard processing protocol with one drop 20% albumin added to hinder cell smudging. Each slide was counted automatically using the CellaVision DM96 and manually by an experienced lab technician. Sputum was classified as eosinophilic or neutrophilic using 3% and 61% cutoffs, respectively. Results: We found a good agreement using intraclass correlation for all target cells, despite significant differences in the cell count rate. The automated CDC had a sensitivity of 65%, a specificity of 93%, and a kappa-coefficient of 0.61 for identification of sputum eosinophilia. In contrast, the automated CDC had a sensitivity of 29%, a specificity of 100%, and a kappa-coefficient of 0.23 for identification of sputum neutrophilia. Conclusion: Automated- and manual cell counts of sputum agree with regards to the key inflammatory cells. The automated cell count had a modest sensitivity but a high specificity for the identification of both neutrophil and eosinophil asthma.

OriginalsprogEngelsk
TidsskriftJournal of Asthma
Vol/bind59
Udgave nummer3
Sider (fra-til)552-560
Antal sider9
ISSN0277-0903
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Authors thank Margit Grome for her expert knowledge and keen guidance in setting up the CellaVision DM96. They also thank The BREATHE-study group for providing a research platform enabling this study.

Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.

Citationsformater